GenSight Biologics S.A. GSGTF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.91M | 1.93M | 2.84M | 2.83M | 317.10K |
| Total Receivables | 2.02M | 2.04M | 1.85M | 1.85M | 1.58M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 329.00K | 332.10K | 180.80K | 180.70K | 442.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 501.50K | 506.20K | 982.70K | 982.00K | 846.70K |
| Total Current Assets | 4.77M | 4.81M | 5.85M | 5.85M | 3.19M |
|
|
|||||
| Total Current Assets | 4.77M | 4.81M | 5.85M | 5.85M | 3.19M |
| Net Property, Plant & Equipment | 327.90K | 330.90K | 501.40K | 501.00K | 816.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00 | 0.00 | 0.00 | 0.00 | 44.60K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.30M | 2.33M | 3.34M | 3.34M | 4.58M |
| Total Assets | 7.40M | 7.47M | 9.69M | 9.69M | 8.63M |
|
|
|||||
| Total Accounts Payable | 6.18M | 6.24M | 6.95M | 6.95M | 10.06M |
| Total Accrued Expenses | 1.75M | 1.76M | 2.51M | 2.51M | 3.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.05M | 4.09M | 4.28M | 4.27M | 16.39M |
| Total Finance Division Other Current Liabilities | 1.54M | 1.55M | 1.14M | 1.14M | 607.20K |
| Total Other Current Liabilities | 1.54M | 1.55M | 1.14M | 1.14M | 607.20K |
| Total Current Liabilities | 13.51M | 13.64M | 14.88M | 14.86M | 30.09M |
|
|
|||||
| Total Current Liabilities | 13.51M | 13.64M | 14.88M | 14.86M | 30.09M |
| Long-Term Debt | 10.62M | 10.71M | 10.82M | 10.81M | 5.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 4.70K | 4.70K | 421.60K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 21.66M | 21.86M | 13.28M | 13.27M | 10.31M |
| Total Liabilities | 45.79M | 46.21M | 38.98M | 38.95M | 46.34M |
|
|
|||||
| Common Stock & APIC | 256.50M | 258.87M | 261.74M | 261.56M | 247.85M |
| Retained Earnings | -11.73M | -11.84M | -14.13M | -14.12M | -8.18M |
| Treasury Stock & Other | -283.16M | -285.77M | -276.90M | -276.70M | -277.37M |
| Total Common Equity | -38.39M | -38.74M | -29.29M | -29.26M | -37.71M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.39M | -38.74M | -29.29M | -29.26M | -37.71M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.39M | -38.74M | -29.29M | -29.26M | -37.71M |
|
|
|||||